Status:
COMPLETED
Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?
Lead Sponsor:
Oregon Health and Science University
Conditions:
Breakthrough Bleeding
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
While there may be a decrease in the total number of bleeding days women experience with continuous-dosed COCs (no menstrual withdrawal week), these regimens frequently result in an increased number o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \> 18 to 49 years old
- Good general health
- No medical contraindications to combined COC therapy.
- In addition, all participants were required to have taken cyclic COCs for at least three months at the time of enrollment, in order to avoid common transition bleeding with the initiation of COCs.
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
August 1 2004
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00120913
End Date
August 1 2004
Last Update
July 19 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OHSU
Portland, Oregon, United States, 97239